Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss in Lymphoma Patients Receiving Chemotherapy.
Phase of Trial: Phase III
Latest Information Update: 01 Jul 2013
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 15 Aug 2010 Planned end date changed from 1 Jan 2010 to 1 Jan 2012 as reported by ClinicalTrials.gov.
- 21 Nov 2009 Status changed from recruiting to active, no longer recruiting as reported by M.D. Anderson Cancer Center record.